← back to search

Ni Chen

Guangzhou University of Chinese Medicine · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Angiogenesis and VEGF in Cancer, MicroRNA in disease regulation, Barrier Structure and Function Studies, and Cancer-related molecular mechanisms research.
h-index
39
citations
5,273
works
259
NIH funding
primary concept
email

Recent publications

PI3K/Akt/GSK3β Activation Mediates the Dual Anti-Melanogenic and Antioxidant Effects of Kadsura coccinea (Lem.) A.C. Smith Leaf Extract
SSRN Electronic Journal 2026cited by 0position: middledoi
In Vitro Structural Characteristics and Antioxidant and Expectorant Activities of Polysaccharides from Citri grandis fructus immaturus
Antioxidants 2025cited by 3position: middledoi
Construction and validation of a nomogram model for cognitive impairment in heart failure patients
Frontiers in Cardiovascular Medicine 2025cited by 1position: firstdoi
Facile Preparation of a Photo-Cross-Linked Silk Fibroin-Poly Ionic Liquid Hydrogel with Antifreezing and Ion Conductive Properties
ACS Applied Materials & Interfaces 2024cited by 22position: middledoi
Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses.
2023cited by 54position: contributordoi
Paeonol alleviates ulcerative colitis in mice by increasing short-chain fatty acids derived from Clostridium butyricum
Phytomedicine 2023cited by 37position: middledoi
Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release.
2023cited by 23position: contributordoi
The Effective Treatment of Purpurin on Inflammation and Adjuvant-Induced Arthritis
Molecules 2023cited by 17position: middledoi
S100A4-dependent glycolysis promotes lymphatic vessel sprouting in tumor.
2023cited by 13position: contributordoi
IFNγ blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins.
2023cited by 5position: contributordoi
Chemical constituents from Mytilaria laosensis Lec. leaves and branches
Biochemical Systematics and Ecology 2023cited by 1position: middledoi
Author Correction: ZIP1<sup>+</sup> fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn<sup>2+</sup> transfer.
2023cited by 0position: contributordoi
Supplementary Table from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Table from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Data from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Table from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Data from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Table from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Data from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Table from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Data from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Table from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Table from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
Supplementary Table from Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells
2023cited by 0position: contributordoi
ZIP1<sup>+</sup> fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn<sup>2+</sup> transfer.
2022cited by 24position: contributordoi
Single-cell transcriptomics analysis reveals intratumoral heterogeneity and identifies a gene signature associated with prognosis of hepatocellular carcinoma.
2022cited by 17position: contributordoi
Dysfunction of S100A4<sup>+</sup> effector memory CD8<sup>+</sup> T cells aggravates asthma.
2022cited by 10position: contributordoi
Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells.
2022cited by 7position: contributordoi
Three new glycosides from the stems of <i>Eurya chinensis</i>  R. Br
Natural Product Research 2022cited by 2position: middledoi
Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response
European Journal of Pharmacology 2021cited by 68position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 18 papers (2019–2023)Zhihai Qin · Institute of Biophysics Chinese Academy of Sciences17 papers (2019–2023) · 13 papers (2022–2023)Ping Yan · Guangzhou University of Chinese Medicine3 papers (2023–2026)Bailin Li · Guangzhou University of Chinese Medicine2 papers (2020–2022)Ruoting Zhan · Guangzhou University of Chinese Medicine2 papers (2023–2025)Huijun Liang · Guangzhou University of Chinese Medicine2 papers (2020–2022)Juanjuan Hu · Inner Mongolia Agricultural University2 papers (2020–2022)Jiewei Wu · Guangzhou University of Chinese Medicine2 papers (2020–2022)Guangjun Nie · CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety2 papers (2019–2019)Dekang Lv · 2 papers (2022–2023)Suifen Mo · Guangzhou University of Chinese Medicine2 papers (2023–2025)Qian-Ran Li · Guangzhou University of Chinese Medicine2 papers (2020–2022)Jie Yuan · Guangzhou University of Chinese Medicine2 papers (2020–2022)Jiannan Chen · Ningbo University1 papers (2021–2021)Yujia Wang · Nanjing Tech University1 papers (2025–2025)Yingxin Liang · Guangzhou University of Chinese Medicine1 papers (2023–2023)Yuanyuan Liang · Guangzhou University of Chinese Medicine1 papers (2021–2021)Kehan Chen · Guangzhou University of Chinese Medicine1 papers (2023–2023)Yunliang Chen · Guangzhou University of Chinese Medicine1 papers (2023–2023)